|
1
|
Ashworth A, Rodrigues G, Boldt G and Palma
D: Is there an oligometastatic state in non-small cell lung cancer?
A systematic review of the literature. Lung Cancer. 82:197–203.
2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Salah S, Tanvetyanon T and Abbasi S:
Metastatectomy for extra-cranial extra-adrenal non-small cell lung
cancer solitary metastases: Systematic review and analysis of
reported cases. Lung Cancer. 75:9–14. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oligometastasis.
|
|
4
|
Yano T, Haro A, Yoshida T, Morodomi Y, Ito
K, Shikada Y, Shoji F, Maruyama R and Maehara Y: Prognostic impact
of local treatment against postoperative oligometastases in
non-small cell lung cancer. J Surg Oncol. 102:852–855.
2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Alongi F, Arcangeli S, Filippi AR, Ricardi
U and Scorsetti M: Review and uses of stereotactic body radiation
therapy for oligometastases. Oncologist. 17:1100–1107.
2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
De Ruysscher D, Wanders R, van Baardwijk
A, Dingemans AM, Reymen B, Houben R, Bootsma G, Pitz C, van Eijsden
L, Geraedts W, et al: Radical treatment of non-small-cell lung
cancer patients with synchronous oligometastases: Long-term results
of a prospective phase II trial (Nct01282450). J Thorac Oncol.
7:1547–1555. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Griffioen GH, Toguri D, Dahele M, Warner
A, de Haan PF, Rodrigues GB, Slotman BJ, Yaremko BP, Senan S and
Palma DA: Radical treatment of synchronous oligometastatic
non-small cell lung carcinoma (NSCLC): Patient outcomes and
prognostic factors. Lung Cancer. 82:95–102. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tree AC, Khoo VS, Eeles RA, Ahmed M,
Dearnaley DP, Hawkins MA, Huddart RA, Nutting CM, Ostler PJ and van
As NJ: Stereotactic body radiotherapy for oligometastases. Lancet
Oncol. 14:e28–e37. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Engels B, Gevaert T, Everaert H, De
Coninck P, Sermeus A, Christian N, Storme G, Verellen D and De
Ridder M: Phase II study of helical tomotherapy in the
multidisciplinary treatment of oligometastatic colorectal cancer.
Radiat Oncol. 7(34)2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Milano MT, Katz AW, Zhang H and Okunieff
P: Oligometastases treated with stereotactic body radiotherapy:
Long-term follow-up of prospective study. Int J Radiat Oncol Biol
Phys. 83:878–886. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hasselle MD, Haraf DJ, Rusthoven KE,
Golden DW, Salgia R, Villaflor VM, Shah N, Hoffman PC, Chmura SJ,
Connell PP, et al: Hypofractionated image-guided radiation therapy
for patients with limited volume metastatic non-small cell lung
cancer. J Thorac Oncol. 7:379–381. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Choi CW, Cho CK, Yoo SY, Kim MS, Yang KM,
Yoo HJ, Seo YS, Kang JK, Lee DH, Lee KH, et al: Image-guided
stereotactic body radiation therapy in patients with isolated
para-aortic lymph node metastases from uterine cervical and corpus
cancer. Int J Radiat Oncol Biol Phys. 74:147–153. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kim MS, Yoo SY, Cho CK, Yoo HJ, Yang KM,
Kang JK, Lee DH, Lee JI, Bang HY, Kim MS and Kang HJ: Stereotactic
body radiotherapy for isolated para-aortic lymph node recurrence
after curative resection in gastric cancer. J Korean Med Sci.
24:488–492. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kim MS, Cho CK, Yang KM, Lee DH, Moon SM
and Shin YJ: Stereotactic body radiotherapy for isolated paraaortic
lymph node recurrence from colorectal cancer. World J
Gastroenterol. 15:6091–6095. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hanna GG and Landau D: Stereotactic body
radiotherapy for oligometastatic disease. Clin Oncol (R Coll
Radiol). 27:290–297. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Duan Y, Li J, Zhang Y, Wang W, Sun X, Fan
T, Shao Q, Xu M, Guo Y and Shang D: Comparison of primary tumour
volumes delineated on four-dimensional computed tomography maximum
intensity projection and (18) F-fluorodeoxyglucose positron
emission tomography computed tomography images of non-small cell
lung cancer. J Med Imaging Radiat Oncol. 59:623–630.
2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Schag CC, Heinrich RL and Ganz PA:
Karnofsky performance status revisited: Reliability, validity, and
guidelines. J Clin Oncol. 2:187–193. 1984.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Trotti A, Colevas AD, Setser A, Rusch V,
Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN and
Rubin P: CTCAE v3.0: Development of a comprehensive grading system
for the adverse effects of cancer treatment. Semin Radiat Oncol.
13:176–181. 2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Greene FL, Page DL, Fleming ID, Fritz AG,
Balch CM, Haller DG and Morrow M (eds): Esophagus. In: American
Joint Committee on Cancer (AJCC) cancer staging manual. 6th
edition. Springer, New York, NY, pp167-178, 2002.
|
|
20
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Pokhrel A, Dyba T and Hakulinen T: A
greenwood formula for standard error of the age-standardised
relative survival ratio. Eur J Cancer. 44:441–447. 2008.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Jereczek-Fossa BA, Beltramo G, Fariselli
L, Fodor C, Santoro L, Vavassori A, Zerini D, Gherardi F, Ascione
C, Bossi-Zanetti I, Mauro R, Bregantin A, Bianchi LC, De Cobelli O
and Orecchia R: Robotic image-guided stereotactic radiotherapy, for
isolated recurrent primary, lymph node or metastatic prostate
cancer. Int J Radiat Oncol Biol Phys. 82:889–897. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Milano MT, Katz AW, Schell MC, Philip A
and Okunieff P: Descriptive analysis of oligometastatic lesions
treated with curative-intent stereotactic body radiotherapy. Int J
Radiat Oncol Biol Phys. 72:1516–1522. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hoyer M, Roed H, Traberg Hansen A, Ohluis
L, Petersen J, Nellemann H, Kiil Berthelsen A, Grau C, Aage
Engelholm S and Von der Maase H: Phase II study on stereotactic
body radiotherapy of colorectal metastases. Acta Oncol. 45:823–830.
2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kim MS, Choi C, Yoo S, Cho C, Seo Y, Ji Y,
Lee D, Hwang D, Moon S, Kim MS and Kang H: Stereotactic body
radiation therapy in patients with pelvic recurrence from rectal
carcinoma. Jpn J Clin Oncol. 38:695–700. 2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Casamassima F, Masi L, Menichelli C,
Bonucci I, Casamassima E, Lazzeri M, Gulisano M and Aterini S:
Efficacy of eradicative radiotherapy for limited nodal metastases
detected with choline PET scan in prostate cancer patients. Tumori.
97:49–55. 2011.PubMed/NCBI
|
|
27
|
Corvò R, Lamanna G, Vagge S, Belgioia L,
Bosetti D, Aloi D, Timon G and Bacigalupo A: Once-weekly
stereotactic radiotherapy for patients with oligometastases:
Compliance and preliminary efficacy. Tumori. 99:159–163.
2013.PubMed/NCBI View Article : Google Scholar
|
